Press release
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Surface Oncology, Regeneron, Clovis Oncology, Zenith Epigenetic, Astellas, Seagen, Pfizer
"Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Metastatic Castration-Resistant Prostate Cancer Therapeutics Market.
The report provides a detailed description of the Metastatic Castration-Resistant Prostate Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Metastatic Castration-Resistant Prostate Cancer Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Metastatic Castration-Resistant Prostate Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Castration-Resistant Prostate Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Metastatic Castration-Resistant Prostate Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Metastatic Castration-Resistant Prostate Cancer treatment market.
Learn More about the Clinical and Commercial Development Activities in the Metastatic Castration-Resistant Prostate Cancer Therapeutics Domain:
https://www.delveinsight.com/report-store/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Metastatic Castration-Resistant Prostate Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Metastatic Castration Resistant Prostate cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Intravenous
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types such as
• Small molecule
• Cell Therapy
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Metastatic Castration-Resistant Prostate Cancer Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Therapeutics Analysis
The treatment paradigm of mCRPC is full of competition as many of the approved therapies are already present in the market and many of the therapies are present in the pipeline for fulfilling the unmet needs in mCRPC treatment.
The dynamics of the mCRPC market are anticipated to change in the coming years owing to the rise in the number of companies taking interest in the development of specific drugs for mCRPC along with increasing awareness and penetration of already approved prostate cancer drugs in mCRPC. Key players.
There are approx. 75+ key companies developing therapies for Metastatic Castration-Resistant Prostate cancer. Currently, Clovis Oncology is leading the therapeutics market with its Metastatic Castration-Resistant Prostate cancer drug candidates in the most advanced stage of clinical development.
Leading Companies in the Metastatic Castration-Resistant Prostate Cancer (mCRPC) Therapeutics Market Include
Surface Oncology, Regeneron Pharmaceuticals, Clovis Oncology, AstraZeneca, Veru Healthcare, Hinova Pharmaceuticals, Zenith Epigenetic, Eli Lilly and Company, Lantern Pharma, Astellas Pharma/Seagen, Pfizer, Progenics Pharmaceutical, Molecular Insight Pharmaceuticals, Bayer, Accutar Biotechnology Inc, Hinova Pharmaceuticals, Taiho Oncology, Inc., Forma Therapeutics, Inc., Dizal Pharmaceuticals, Amgen, among others
Emerging and Marketed Metastatic Castration-Resistant Prostate Cancer (mCRPC) Therapies Covered in the Report Include
• Proxalutamide (GT0918): Suzhou Kintor Pharmaceutical
• Opdivo (nivolumab): Bristol-Myers Squibb
• 177Lu-PSMA-617: Novartis
• HC-1119: Hinova Pharmaceuticals
• EPI-7386: ESSA Pharmaceuticals
• ODM-208: Orion Pharma
• Sacituzumab Govitecan (IMMU-132): Immunomedics
• Keytruda (Pembrolizumab/MK-3475): Merck Sharp & Dohme
• Ipatasertib (RG7440): Hoffmann-La Roche
• Talazoparib: Pfizer/Astellas Pharma
• Capivasertib (AZD5363): AstraZeneca
• AZD4635: AstraZeneca
• Abemaciclib (LY2835219): Eli Lilly and Company
• Niraparib: Janssen Research & Development
• Onvansertib: Cardiff Oncology
• LAE001: Laekna Therapeutics
• SRF617: Surface Oncology
• Rucaparib: Clovis Oncology
• HP518: Hinova Pharmaceuticals
• Xofigo (radium Ra 223 dichloride): Bayer Health Care
• Xtandi (Enzalutamide): Astellas Pharma
• Erleada (apalutamide): Janssen Pharmaceutical
• Jevtana (Cabazitaxel): Sanofi
• Rubraca (Rucaparib): Clovis Oncology
• Lynparza (Olaparib): AstraZeneca/ Merck Sharp & Dohme
And Many More
Get an in-depth Assessment of the Emerging Therapies and Metastatic Castration-Resistant Prostate Cancer Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Metastatic Castration-Resistant Prostate Cancer Current Treatment Patterns
4. Metastatic Castration-Resistant Prostate Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Metastatic Castration-Resistant Prostate Cancer Late-Stage Products (Phase-III)
7. Metastatic Castration-Resistant Prostate Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Metastatic Castration-Resistant Prostate Cancer Discontinued Products
13. Metastatic Castration-Resistant Prostate Cancer Product Profiles
14. Metastatic Castration-Resistant Prostate Cancer Companies
15. Metastatic Castration-Resistant Prostate Cancer Drugs
16. Dormant and Discontinued Products
17. Metastatic Castration-Resistant Prostate Cancer Unmet Needs
18. Metastatic Castration-Resistant Prostate Cancer Future Perspectives
19. Metastatic Castration-Resistant Prostate Cancer Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Healthcare Consulting and Competitive Intelligence Services by DelveInsight
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market
Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
Status Epilepticus Market
https://www.delveinsight.com/report-store/status-epilepticus-market
Brain Hemorrhage Market
https://www.delveinsight.com/report-store/brain-hemorrhage-market
Congenital Adrenal Hyperplasia Market
https://www.delveinsight.com/report-store/congenital-adrenal-hyperplasia-market
Ductal Carcinoma in Situ Market
https://www.delveinsight.com/report-store/ductal-carcinoma-in-situ-market
Electroencephelographs (EEG) Pipeline Insight
https://www.delveinsight.com/report-store/electroencephelographs-eeg-pipeline-insight-and-competitive-landscape
Spinal Decompression/Traction Devices Market
https://www.delveinsight.com/report-store/spinal-decompression-traction-devices-market
Bronchopulmonary Dysplasia Market
https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
Drug Hypersensitivity Market
https://www.delveinsight.com/report-store/drug-hypersensitivity-market
Familial Chylomicronemia Syndrome (FCS) Market
https://www.delveinsight.com/report-store/familial-chylomicronemia-syndrome-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Postmyocardial Infarction Syndrome Market
https://www.delveinsight.com/report-store/postmyocardial-infarction-syndrome-market
Surgery and Radiation Therapy in Brain Cancer Market
https://www.delveinsight.com/report-store/surgery-and-radiation-therapy-in-brain-cancer-market
Acute ischemic stroke (AIS) Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market
Biliary Tract Cancers (BTCs) Market
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market
Hemophagocytic Lymphohistiocytosis Market
https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market
Staphylococcus Aureus Infection Market
https://www.delveinsight.com/report-store/staphylococcus-aureus-infection-market
Treatment-Resistant Hypertension Market
https://www.delveinsight.com/report-store/treatment-resistant-hypertension-market
Urticaria Or Hives Market
https://www.delveinsight.com/report-store/urticaria-or-hives-market
Acute Heart failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market
Contrast-Induced Nephropathy Market
https://www.delveinsight.com/report-store/contrast-induced-nephropathy-market
Delirium Market
https://www.delveinsight.com/report-store/delirium-market
Dry AMD MarketEGFR Inhibitors-Induced Skin Disorders Market
https://www.delveinsight.com/report-store/egfr-inhibitors-induced-skin-disorders-market
Excessive Daytime Sleepiness (EDS) Market
https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market
Gene and Cell Therapies Targeting CNS Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-targeting-cns-disorders-market
Glioma Market
https://www.delveinsight.com/report-store/glioma-market
Graves Ophthalmopathy Market
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market
H3N2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market
Nontuberculous Mycobacterial (NTM) Infections Market
https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market
Pneumothorax Treatment Devices Market
https://www.delveinsight.com/report-store/pneumothorax-treatment-devices-market
Portal Hypertension Market
https://www.delveinsight.com/report-store/portal-hypertension-market
Decompensated Cirrhosis Market
https://www.delveinsight.com/report-store/decompensated-cirrhosis-market
Follicular Lymphoma Market
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights
Osteochondromas Market
https://www.delveinsight.com/report-store/osteochondromas-market
Hidradenitis Suppurativa Market
https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
IgG4-Related Disease Market
https://www.delveinsight.com/report-store/igg4-related-disease-market
Lichen Planus Market
https://www.delveinsight.com/report-store/lichen-planus-market
Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
Meniere's Disease Market
https://www.delveinsight.com/report-store/menieres-disease-md-market
Cytokine Release Syndrome Market
https://www.delveinsight.com/report-store/cytokine-release-syndrome-market
Angelman Syndrome Market
https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast
Eosinophilic Gastroenteritis (EGE) Market
https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-market
Hereditary Transthyretin Amyloidosis (hATTR) Market
https://www.delveinsight.com/report-store/hereditary-transthyretin-amyloidosis-competitive-landscape-and-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Post-Operative Cataract Surgery Inflammation Market
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market
Antibody-mediated Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Surface Oncology, Regeneron, Clovis Oncology, Zenith Epigenetic, Astellas, Seagen, Pfizer here
News-ID: 3185064 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Resistant
Fire resistant board: a new building material that is fire-resistant, durable, a …
With the continuous development of the construction industry, the requirements for building materials are also increasing. As a new type of building material, fire-resistant board has the advantages of fire resistance, durability, and aesthetics, and is gradually favored by architects and consumers. This article will provide a detailed introduction to the advantages and functions of refractory boards.
1 Fire resistance performance
Refractory board is a building material with excellent fire resistance performance.…
Treatment-Resistant Depression Market Overview
Treatment-resistant depression (TRD) is a condition where patients with major depressive disorder do not respond to at least two different antidepressant treatments. It poses a significant challenge in mental health care, affecting millions worldwide who struggle to find effective treatment. The condition often results in a higher burden on patients, caregivers, and healthcare systems, leading to increased demand for novel therapies. This article covers the treatment-resistant depression market, its size,…
Bullet Resistant Doors Market Emerging Trends || Leading Players are Bullet Resi …
The Global Bullet Resistant Doors Market analysis report published on IndustryGrowthInsights.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.
Get FREE Exclusive PDF Sample Copy of This…
SwiftDao: Fraud Resistant Blockchain Governance
Blockchain project failure rates hover around 92% with an average lifetime of 1.22 years. In many cases, managers take investor’s money and leave a trail of abandonware behind. Crowdfunded projects stealing money from small investors are the most tragic, but the high rate of failure has scared away institutional investment which reached new lows in 2019. A new solution is needed. Enter SwiftDao, a new standard for building fraud resistant…
Plasterboard Market Report 2018: Segmentation by Type (Standard, Fire-Resistant, …
Global Plasterboard market research report provides company profile for Armstrong World Industries Inc. (U.S.), Etex Group (Belgium), Saint-Gobain S.A. (France), Gypsum Management and Supply, Inc. (U.S.), USG Corporation (U.S.), Georgia Pacific LLC (U.S.), Boral Limited (Australia) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Resistant Dextrin Market: Inclusion of Resistant Dextrin in the Category of Diet …
Obtained from starches, resistant dextrin which essentially is a dietary fiber forms an active ingredient in various nutritional products. Further, proliferated use of resistant dextrin in food, beverage, and pharmaceutical industries has contributed substantially towards the growth of resistant dextrin market. To evaluate the implications of recent developments on the growth of dextrin market, Market Research Hub (MRH) has added a new report titled, ‘Global Resistant Dextrin Market by Manufacturers, Regions,…
